Blog Archives

PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms

VIEW PRESS RELEASE [PDF] 04 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson’s therapy in

Tagged with: , , , , , , , , , , ,

PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities

VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor

Tagged with: , , , , , , , , , , , ,

PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by

Tagged with: , , , , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The

Tagged with: , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress

Tagged with: , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of

Tagged with: , , , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of

Tagged with: , , , , , , , , , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment

Tagged with: , , , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders

VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential

Tagged with: , , , , , , , , ,